Neuralstem Achieves 50% Enrollment in NSI-189 Phase 2 Trial in Major Depressive Disorder

Sep 21, 2016 12:32 pm UTC| Business

GERMANTOWN, Md., Sept. 21, 2016 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced that it...

oti Receives Order for 65,000 Cashless Payment Devices from a North American Customer

Sep 21, 2016 12:31 pm UTC| Business

Shipments to start immediately with projected fulfillment date of Q1 2017Serves growing demand for cashless and contactless transactionsoti captures growing market share in vending machine marketROSH PINA, Israel, Sept. ...

MX Gold Corp. Updates Shareholders on Willa and Max Mill Sites

Sep 21, 2016 12:30 pm UTC| Business

VANCOUVER, British Columbia, Sept. 21, 2016 -- MX Gold Corp. (TSX-V:MXL) (FSE:ODV) (OTCQX:MXLGF) (the “Company” or “MX Gold”) is pleased to announce current work programs/permitting at the Willa and Max Mill Sites are...

BidEnergy Brings Breakthrough Spend Management Platform to U.S., Automating the “Source-to-Pay” Process for Energy

Sep 21, 2016 12:30 pm UTC| Business

Cloud-based Platform Marries Combinatorial Auctions and Robotic Process Automation to Increase Companies’ Control over Energy Spend and Data Company Introduces Phil Adams as U.S. CEO CONCORD, Mass. and MELBOURNE,...

EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference

Sep 21, 2016 12:30 pm UTC| Business

WALTHAM, Mass., Sept. 21, 2016 -- EyeGate Pharmaceuticals, Inc. (Nasdaq:EYEG), (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating...

Cellectar Biosciences To Present at OktoberINVESTfest

Sep 21, 2016 12:30 pm UTC| Business

MADISON, Wis., Sept. 21, 2016 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused biotechnology company, today announces that Jim Caruso, president and CEO of Cellectar, will present at the...

Skyline Medical and GLG Pharma Enter into Partnership to Develop Diagnostic Tests for Skyline’s STREAMWAY System

Sep 21, 2016 12:30 pm UTC| Business

MINNEAPOLIS, Sept. 21, 2016 -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing...